Advertisement

Topics

Dainippon Sumitomo Pharma Co., Ltd. Company Profile

09:37 EDT 19th September 2017 | BioPortfolio

Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP's strong research and development presence in the areas of CNS, diabetes, cardiovascular disease, and inflammation/allergy, is based on the merger in 2005 between Sumitomo Pharmaceuticals Co., Ltd., and Dainippon Pharmaceutical Co., Ltd. With global expansion plans on the horizon, this multi-billion dollar company has about 5,000 employees worldwide. Through its research and development efforts, DSP aims to extend its experience, commitment and vision worldwide. Located in Fort Lee, NJ, Dainippon Sumitomo Pharma America, Inc. is a subsidiary of DSP.


News Articles [2367 Associated News Articles listed on BioPortfolio]

Sumitomo Dainippon seeks new indication for PD drug in Japan

Tokyo’s Sumitomo Dainippon Pharma has applied to extend its Japanese marketing authorization for Parkinson’s…

Sumitomo Dainippon Pharma Co., Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 14062017] Prices from USD $350

Sumitomo Dainippon Pharma Co., Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sumitomo Dainippon Pharma Co., Ltd. Mergers Acquisitions MA, Partnershi...

Sumitomo Dainippon Cancer Stemness Inhibitor Napabucasin Disappoints in Phase III

Sumitomo Dainippon Pharma is unblinding the global Phase III BRIGHTER study evaluating its cancer stemness inhibitor napabucasin (BBI-608) in patients with gastric and gastro-esophageal junction (GEJ)...

Hoped-for COPD approval fades with FDA rejection

Shares of Sumitomo Dainippon Pharma slumped as its COPD inhaler was knocked back by the FDA. 

Sunovion files for approval to market new ADHD drug in the USA

Sunovion Pharmaceuticals, a wholly owned subsidiary of Japanese drugmaker Sumitomo Dainippon Pharma,…

Study shows effect of Sunovion bipolar drug in children and adolescents

Sunovion Pharmaceuticals, a US subsidiary of Japanese pharma company Sumitomo Dainippon, has announced…

Hoped-for approval stumbles with COPD rejection

Sumitomo Dainippon Pharma shares slump as COPD inhaler approval is knocked back by the FDA. 

Maruishi gets rights to antiemetic in all-Japanese deal

Maruishi Pharmaceutical is to pay fellow Japanese drugmaker Sumitomo Dainippon Pharma for exclusive development,…

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [31 Associated PubMed Articles listed on BioPortfolio]

Lurasidone: Efficacy and Safety in the Treatment of Psychotic and Mood Disorders.

Lurasidone ([3aR,4S,7R,7aS]-2-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1yl-methyl] cyclohexylmethyl]-hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride; Latuda® [LRSD]) is a novel ben...

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

AI-powered drug discovery captures pharma interest.

Clinical Trials [73 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [727 Associated Companies listed on BioPortfolio]

Dainippon Sumitomo Pharma America, Inc.

Dainippon Sumitomo Pharma America, Inc. (DSPA) located in Fort Lee, N.J., is a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP). On April 1, 2010, DSP's two North American operations - DSPA and...

Dainippon Sumitomo Pharma Co., Ltd.

Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP's strong...

Chelsea Therapeutics International, Ltd.

Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires, develops and commercializes innovative products for the treatment of a variety of huma...

Sumitomo Heavy Industries, Ltd.

Sumitomo Heavy Industries, Ltd. (TOKYO:6302) is a technology-oriented Japanese manufacturer of medical and industrial machinery. Its accelerator technology is widely used in the s...

Sumitomo Corporation Europe Limited

Sumitomo Corporation Europe is a principal subsidiary of Sumitomo Corporation, a leading integrated trading company with its headquarters in Japan, and as such we share in its key role in the exchange...

More Information about "Dainippon Sumitomo Pharma Co., Ltd." on BioPortfolio

We have published hundreds of Dainippon Sumitomo Pharma Co., Ltd. news stories on BioPortfolio along with dozens of Dainippon Sumitomo Pharma Co., Ltd. Clinical Trials and PubMed Articles about Dainippon Sumitomo Pharma Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dainippon Sumitomo Pharma Co., Ltd. Companies in our database. You can also find out about relevant Dainippon Sumitomo Pharma Co., Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...


Corporate Database Quicklinks



Searches Linking to this Company Record